CORRIGENDUM: Synthesis of 1,2,3-Triazole-Methyl-Menadione Derivatives: Evaluation of Electrochemical and Antiparasitic Properties against two Blood-Dwelling Parasites

IF 3.6 4区医学 Q2 CHEMISTRY, MEDICINAL

ChemMedChem Pub Date : 2025-02-13 DOI:10.1002/cmdc.202500043

引用次数: 0

Abstract

Baptiste Dupouy,^[a] Tanja Karpstein,^[b,c] Cécile Häberli,^[b,c] Monica Cal,^[b,c] Dr. Matthias Rottmann,^[b,c] Prof. Dr. Pascal Mäser,^[b,c] Prof. Dr. Jennifer Keiser,^[b,c] Dr. Mourad Elhabiri,^[a] Dr. Elisabeth Davioud-Charvet*^[a]

[a] Laboratoire d'Innovation Moléculaire et Applications (LIMA), Team Bio(IN)organic & Medicinal Chemistry, UMR7042 CNRS-Université de Strasbourg-Université Haute-Alsace, European School of Chemistry, Polymers and Materials (ECPM), 25, rue Becquerel, F-67087 Strasbourg, France

E-mail: [email protected]

[b] Swiss Tropical and Public Health Institute, Kreuzstrasse 2, CH-4123 Allschwil, Switzerland

[c] University of Basel, Petersgraben 1, CH-4001 Basel, Switzerland

Upon original publication in Early View, Dr. B. Cichocki was mistakenly listed as a co-author. The correct author listing is shown above.

查看原文本刊更多论文

更正：1,2,3-三唑-甲基甲萘醌衍生物的合成：对两种血栖寄生虫的电化学和抗寄生性能的评价。

Baptiste Dupouy,[a] Tanja Karpstein,[b,c] c,[b,c] Monica Cal,[b,c] Dr. Matthias Rottmann,[b，c]教授。Pascal Mäser,[b，c]教授，博士。Jennifer Keiser,[b，c] Mourad Elhabiri博士，[a] Elisabeth david - charvet博士*[a][a] Laboratoire d'Innovation mol culaire et Applications (LIMA), Team Bio(IN)organic &；药物化学，UMR7042 cnrs -斯特拉斯堡大学-上阿尔萨斯大学，欧洲化学、聚合物和材料学院（ECPM）， 25, rue Becquerel, F-67087 Strasbourg， france - e- mail: [email protected][b]瑞士热带和公共卫生研究所，Kreuzstrasse 2, CH-4123 Allschwil， Switzerland[c]巴塞尔大学，Petersgraben 1, CH-4001 Basel， Switzerland在Early View最初发表时，b . Cichocki博士被错误地列为合著者。正确的作者列表如上所示。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ChemMedChem 医学-药学

CiteScore

6.70

自引率

2.90%

发文量

280

审稿时长

1 months

期刊介绍： Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.